Proprietary IP

Canonic is protecting its IP by filing breeders right for its commercial varieties in each territory.
The company has filed to date in Israel and in the EU. Moreover, Canonic has filed a provisional application in the U.S. for its Prcise varieties clinical activity.


Exclusive Access to an
Immense IP Portfolio

Canonic’s parent company, Evogene, is ranked among the ten leading companies in plant genetics patents and innovation. Thousands of patents backed by deep life sciences expertise puts Canonic in a leading position to developing the next-generation of Cannabis products. The IP portfolio covers major attributes directly related to Cannabis key traits development.

Stress tolerance

Growth rate


Plant architecture


Disease resistance